Recent research suggests that transglutaminase 2 (TG2) plays a critical role in Aβ peptide aggregation in Alzheimer’s disease (AD), contributing to the neurotoxic effects associated with Aβ accumulation [28,29,30,32,33,34]. This evidence concerns the gene TGM2 and early-onset autosomal dominant Alzheimer disease.